Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;27(1):525-531.
doi: 10.1007/s40199-019-00252-9. Epub 2019 Mar 22.

Vitamin B combination reduces fluconazole toxicity in Wistar rats

Affiliations

Vitamin B combination reduces fluconazole toxicity in Wistar rats

Fahad A Al-Abbasi et al. Daru. 2019 Jun.

Abstract

Background: The major adverse effect associated with systemic administration of Fluconazole (FLZ), is hepatic toxicity. FLZ is most commonly used antifungal drug in treatment of invasive fungal infections.

Methods: FLZ toxicity was challenged by individual and in combination of three vitamins (B1, B2 B3). Animals were divided nine groups with six animals in each group. FLZ, at a dose of 50 mg/kg b.w, was orally administered for 90 days in experimental animals. Vitamins as individual or in combination was administered concomitantly to challenge or alleviate the toxicity of FLZ. They were sacrificed at the end of protocol for biochemical and histopathology analysis. Focus was made to observe the role of these micro nutrient's (vitamins) on liver for alteration in of pathological and physiological effects by FLZ in the Wistar albino rats.

Results: Combination of vitamin B1 + B2 + B3 in FLZ induced toxicity was able to restore the level of alkaline phosphatase (ALP) near to normal but with high level of ALP in B1 Control group. Aspartate aminotransferase (AST) was restored to normal in FLZ + B1, FLZ + B2 and FLZ + B1 + B2 + B3 groups and vice versa in FLZ + B3 group animals. Further the level of alanine aminotransferase (ALT) was restored to normal in FLZ + B3 animals. There were no significant changes found in total bilirubin (TBI), and direct bilirubin (DBI) as compare to normal control. Histopathological studies on animals' studies validated the serological results in normalizing the cellular architecture of liver.

Conclusions: Restoration of altered biochemical parameters and cellular architecture of hepatocytes by different combination of these vitamins proves the chemo preventive potential of these micro nutrients' in FLZ toxicity. Graphical abstract Vitamin B combination attenuates fluconazole toxicity.

Keywords: Fluconazole; Niacin; Riboflavin; Thiamine; Toxicity.

PubMed Disclaimer

Conflict of interest statement

The Authors declare that there is no conflict of interest.

Figures

Graphical abstract
Graphical abstract
Vitamin B combination attenuates fluconazole toxicity.
Fig. 1
Fig. 1
Effect of vitamins (B1, B2 and B3) in FLZ administered hepatotoxicity in different groups of rats: a Normal control; b FLZ control; c B1 control; d B2 control; e B3 control; f FLZ + B1 group; g FLZ + B2; h FLZ + B3; i FLZ + B1 + B2 + B3. The above pictures for each group were chosen randomly. Black arrows depict bi-nucleated cellular architecture. The slides were H&E stained and the original magnification was 40×

Similar articles

References

    1. Cavayas YA, Yusuff H, Porter R. Fungal infections in adult patients on extracorporeal life support. Crit Care. 2018;22(1):98. doi: 10.1186/s13054-018-2023-z. - DOI - PMC - PubMed
    1. O'Leary RA, Einav S, Leone M, Madách K, Martin C, Martin-Loeches I. Management of invasive candidiasis and candidaemia in critically ill adults: expert opinion of the European Society of Anaesthesia Intensive Care Scientific Subcommittee. J Hosp Infect. 2018;98(4):382–390. doi: 10.1016/j.jhin.2017.11.020. - DOI - PubMed
    1. Cho SY, Lee DG, Choi JK, Lee HJ, Kim SH, Park SH, Choi SM, Choi JH, Yoo JH, Kim YJ, Kim HJ, Min WS, Back H, Kang S, Lee EK. Cost-benefit analysis of Posaconazole versus FLZ or Itraconazole as a primary antifungal prophylaxis in high-risk hematologic patients: a propensity score-matched analysis. Clin Ther. 2015;37(9):2019–2027. doi: 10.1016/j.clinthera.2015.06.014. - DOI - PubMed
    1. van Prehn J, Menke-van der Houven van Oordt CW, de Rooij ML, Meijer E, Bomers MK, van Dijk K. Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis? Oncologist. 2017;22(8):989–994. doi: 10.1634/theoncologist.2017-0019. - DOI - PMC - PubMed
    1. Malhi V, Colburn D, Williams SJ, Hop CE, Dresser MJ, Chandra P, Graham RA. A clinical drug-drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib. Cancer Chemother Pharmacol. 2016;78(1):41–49. doi: 10.1007/s00280-016-3020-z. - DOI - PMC - PubMed